| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 95,377 | 98,289 | 93,593 | 102,715 | | Cost of Revenue | 64,515 | 68,252 | 62,632 | 69,812 | | | Gross Profit | 30,862 | 30,037 | 30,961 | 32,903 | | | Operating Expenses | | Research Development | 11,455 | 10,779 | 10,572 | 11,358 | | Selling General and Administrative | 19,403 | 18,726 | 18,884 | 19,564 | | Non Recurring |
-
| 3,131 |
-
| 3,488 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4 | (2,599) | 1,505 | (1,507) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (143) | (70) | 373 | 1,231 | | Earnings Before Interest And Taxes | 37 | (2,669) | 1,878 | (276) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 37 | (2,669) | 1,878 | (276) | | Income Tax Expense | 11 | (2,384) | (373) | (1,695) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 26 | (285) | 2,251 | 1,419 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 26 | (285) | 2,251 | 1,419 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $26 | ($285) | $2,251 | $1,419 |
|
0.02% Nasdaq 0.00%
Income Statement
